We have constructed a nondefective recombinant virus between the nononcogenic adenovirus S (AdS) and the highly oncogenic AdM2. The recombinant genome consists essentially of Ad5 sequences, with the exception of the transforming early region 1 (El) which is derived from Adl2. HeLa cells infected with the recombinant virus were shown to contain the Adl2-specific El proteins of 41 kilodaltons (Ela) and 19 and 54 kilodaltons (both encoded by Elb). The recombinant virus replicated efficiently in human embryonic kidney cells and HeLa cells, showing that the transforming regions of Ad5 and Adi2 had similar functions in productive infection. After the recombinant virus was injected into newborn hamsters, no tumors were produced during an observation period of 200 days. Thus, despite the fact that all products required for oncogenic transformation in vitro were derived from the highly oncogenic Adl2, the recombinant virus did not produce tumors in vivo. These data show that tumnor induction by adenovirus virions is not determined only by the gene products of the transforming region.
Human adenovirus 12 (Adl2) efficiently induces tumors in newborn hamsters after a short latency period, whereas Ad5 completely fails to do so (11) . Likewise, rat cells transformed in vitro by Adl2 are highly oncogenic in immunocompetent syngeneic rats and immunodeficient nude mice (1, 14, 16, 21, 24, 28, 34) , whereas cells transformed by nononcogenic adenoviruses are, in general, nononcogenic in immunocompetent rats and only moderately oncogenic in nude mice (1, 15, 21, 29) .
The region responsible for cell transformation in vitro coincides with the first region expressed early in productive infection, indicated as early region 1 (El) (13) . The El region of both oncogenic and nononcogenic adenoviruses is located at the left end of the viral genome and consists of two independent transcription units, Ela and Elb (13) . Both regions Ela and Elb are required for cell transformation in vitro and contribute to the oncogenic potential of the transformed cells. Rat cells expressing only region Ela of AdS exhibit a semi-transformed phenotype and are nononcogenic in nude mice (23; P. J. van den Elson, Ph.D. thesis, State University of Leiden, Leiden, The Netherlands, 1982), and similar properties have been described for cells that express a normal Elb region but carry a mutation in region Ela (5, 18, 32) .
Studies with rat cells transformed by Ad5/Adl2 hybrid El plasmids (1) have shown that two genes are responsible for the observed difference in oncogenicity between AdS-and Adi2-transformed cells; one was localized in Ela and one was localized in Elb. The protein translated from the 13S Ela mRNA of Adl2, but not that of AdS, has been shown to suppress the expression of class I transplantation antigens in transformed cells and thereby allows transformed cells to evade elimination by host cytotoxic T cells (3, 33 that it determines the efficiency with which the transformed cells induce tumors: if region Elb is derived from AdS, tumor induction is inefficient, whereas if it is derived from Adl2, the tumors are readily induced (1, 3) . This different behavior of the AdS and Adl2 Elb regions has been attributed to differences in the primary structure of the 54 to 58-kilodalton (kD) polypeptide (2) .
An essential question is whether oncogenicity of adenovirus virions in vivo is solely dependent on the identity of the El products, as is the case for oncogenic transformation in vitro, or whether genes located in the remaining 90% of the viral genome also contribute to the oncogenic properties of the virus. To answer this question, we After absorption of the virus for 1 h at 37°C, the cells were washed three times with PBS to remove unabsorbed virus and fed 5 ml of minimal essential medium-2% fetal calf serum. After 1 h, cells and medium were collected from one of the dishes (t = 0, control); the other dish was incubated for 4 days at 37°C before cells and medium were collected. After 6 cycles of freezing and thawing, cell debris was removed by centrifugation, and serial dilutions of the supernatant were made in PBS-2% fetal calf serum and used to infect 293 cells for a plaque assay. Procedures for 35S labeling and immunoprecipitation have been described previously (1).
Recombinant DNA techniques. Plasmid p5125E1 was constructed from a plasmid containing the Ad12 EcoRI C fragment (pAd12RIC) (6) . In the first step, the left terminal PvuII fragment (nucleotides 0 to 398) of Ad12 in this plasmid was replaced by the left terminal PvuII fragment of AdS (nucleotides 79 to 451, isolated from pAdS XhoC [1] ). In the second step, this plasmid was further modified by removing A EIa the Adl2 sequences downstream from the Elb polyadenylation signal. Finally, to obtain homologous recombination with the d1309 Xba A fragment, the AdS BglII B fragment was ligated downstream from Adl2 Elb, yielding p5125E1. Methods used for these constructions have been described previously (1, 2, 6) . Before transfection into 293 cells, the plasmid was digested with EcoRI. This enzyme cleaves the plasmid once at 29 base pairs left of the AdS inverted terminal repetition (ITR).
Isolation of recombinant viruses. The isolation of the Ad5 d1309 Xba A fragment-terminal protein complex has been described previously (4) . To obtain Ad5/Adl2 recombinants, human 293 cells in 6 cm dishes were cotransfected with 1 ,ug of the Xba A fragment and 5 ,ug of EcoRI-linearized plasmid p5125E1 by the calcium phosphate coprecipitation technique (39) . At 4 h after transfection, the medium was removed. The cells were washed twice with PBS to remove the precipitate, and the cells were overlaid with agar as described above. After 9 to 10 days, individual plaques were picked and, after To identify recombinant viruses, individual plaques from the cotransfection assay were picked and used to infect 293 cells in 6-cm dishes. After 3 to 4 days, viral DNA was purified from the infected cells and analyzed by digestion with restriction endonuclease Sall. If homologous recombination had occurred between the plasmid and the d1309 XbaI A fragment, the resulting recombinant genome would have an additional Sall site located at 10 map units when compared with AdS d1309 (Fig. 3B) . One of the plaques, RC1S, had a novel SalI digestion pattern (Fig. 3A) . The disappearance of the left-terminal SalIB band and the appearance of two novel bands of 10 and 16 map units (Fig. 3A , left panel, lane 4) was consistent with the insertion of the Adl2 El region at the left end of the AdS genome. Additional fine mapping of the recombinant genome further confirmed the organization of RC15 as presented in Fig. 3B .
Transfer of an intact region E3 into the recombinant virus. The AdS mutant d1309 used to construct RC15 lacked three of the four XbaI cleavage sites present in AdS (26) . Although d1309 is nondefective in HeLa cells, at least one of the XbaI sites was lost as a result of a deletion (83 to 85 map units) mapping in E3 (26) . One of the products of this region is a 19-kD glycoprotein which has been shown to be associated with the class I transplantation antigens in transformed cells (35 (Fig. 5) . Proteins of the same molecular weights were detected in Adl2-infected cells, although the expression of the 54-kD protein seemed somewhat reduced in the recombinant-virus-infected cells. The 41-kD protein is the major product of Adl2 Ela, and the 19-kD and 54-kD proteins have been shown to be encoded by Elb (25) . The only protein that could be precipitated with the AdS antiserum from RC1S-and RC15GT-infected cells, but not from Adl2-infected cells, was 14 kD and is probably encoded by AdS E4 (10) . When HeLa cells were infected with any of the three viruses and labeled 5 to 9 h postinfection, only the 41-kD Adl2 Ela protein could be precipitated (data not shown).
We conclude from these experiments that the El region of Adl2 in the recombinant genome is, both qualitatively and temporally, faithfully expressed.
Ad5/Adl2 recombinant virus found to be nondefective. It is well documented that adenoviruses with mutations in either region Ela or region Elb are defective for growth in HeLa cells (17, 20, 22, 26 but nonpermissive for Adl2 (9, 38) , and it has been suggested that replication of Ad5 in hamster cells prevents oncogenesis (30) . Because (7, 31, 40) .
Surprisingly, the recombinants did not induce tumors when injected into newborn hamsters. A positive result was anticipated because hamster cells transformed in vitro by Adl2 are highly oncogenic when transplanted into hamsters (27) , and in the recombinant virus, all sequences required for oncogenic transformation in vitro were derived from Adl2. There could be several reasons for this negative result. First, the AdS mutant d1309, which was used to construct the first Ad5-Adl2 recombinant (RC15), lacks three XbaI cleavage sites when compared with AdS (26) . It could be argued that the loss of these sites introduces mutations in the genome of d1309 (and thus of RC15) in regions required for manifestation of the oncogenic phenotype. Especially the loss of the XbaI site in E3 was initially thought to be of importance in this respect, since E3 encodes a glycoprotein which is associated with the major histocompatibility class I antigens in transformed cells (35) . However, the recombinant RC15GT, which has an intact E3 region, was similarly nononcogenic. We hamsters might therefore be due not to an inherent inability of in vivo transformed cells to grow out and form a tumor but rather to an inability to cause transformation in vivo. Failure to transform in vivo could be related to permissivity, as it has been shown that the ability of adenoviruses to transform cells in vitro is inversely correlated with permissivity (12) . For example, human cells are fully permissive for Ad5 and Adl2, and transformation of human cells with virus has never been reported, although transformation with subgenomic DNA fragments is possible (8, 19 ) and hamster cells, for which Ad5 is semipermissive, can be transformed efficiently only when the replicating capacity of the virus has been abolished by using nonpermissive mutants (30, 37, 41) . The simplest explanation for these observations is that cells in which replication takes place are killed before transformation can occur. Thus, the lack of oncogenicity of Ad5 in hamsters could also be due to the fact that AdS, but not Adl2, can replicate in hamster cells (9, 38) . This view is further supported by the demonstration that hamster cells transformed in vitro by AdS are oncogenic in newborn hamsters (41) . Our present results indicate that the AdS/ Adl2 recombinant virus, when compared with AdS, has a limited capacity to replicate in hamster cells. However, BHK-21 cells are clearly more permissive for the recombinant virus than for Adl2, for which these cells are strictly nonpermissive (Table 1) . At this stage, we cannot estimate the extent to which the limited replication of the recombinant virus in hamster cells contributes to the nononcogenic character of the virus. Definite proof for this relation has to await the construction of an AdS/Adl2 recombinant virus that is strictly nonpermissive for growth in hamster cells.
